What is Pegasta Injection 6 mg?

Pegasta Injection 6 mg is a prescription medicine that contains Pegfilgrastim, a long-acting form of granulocyte colony-stimulating factor (G-CSF). It belongs to a class of medicines known as hematopoietic growth factors, which help the body produce white blood cells called neutrophils.

Pegfilgrastim is commonly prescribed for patients receiving chemotherapy that may lower white blood cell counts and increase the risk of serious infections. By stimulating the bone marrow to produce more neutrophils, Pegasta helps strengthen the body’s immune defenses during cancer treatment.

Manufactured by Intas Pharmaceuticals Ltd., Pegasta Injection is supplied as a 6 mg/0.6 mL single-use prefilled syringe intended for subcutaneous (under the skin) administration.

Doctors prescribe Pegasta to reduce the duration of low white blood cell counts and decrease the likelihood of infection-related complications associated with chemotherapy.

This medicine should only be used under the supervision of a qualified healthcare professional. Self-medication is not recommended.

---

Uses of Pegasta Injection 6 mg

Pegasta Injection is prescribed for medically approved indications, including:

• Reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy
• Shortening the duration of chemotherapy-induced neutropenia
• Supporting recovery of white blood cell counts after chemotherapy
• Helping lower the risk of serious bacterial infections caused by low neutrophil levels
• Supportive care in selected cancer treatment protocols as determined by the treating oncologist

This medicine should only be taken under the supervision of a qualified healthcare professional.

---

Benefits of Pegasta Injection 6 mg

Pegasta provides important support during cancer treatment by helping maintain healthy neutrophil levels.

Benefits include:

• Helps reduce the duration of low white blood cell counts
• Lowers the risk of chemotherapy-related infections
• Supports the body’s natural immune response
• May reduce the need for hospitalization due to febrile neutropenia
• Helps patients continue planned chemotherapy schedules
• Supports overall recovery after chemotherapy
• Improves quality of life by reducing infection-related complications

Pegasta helps manage treatment-related complications but is not a cure for cancer.

---

How Does Pegasta Injection 6 mg Work?

Pegfilgrastim is a long-acting version of granulocyte colony-stimulating factor (G-CSF). After administration, it binds to receptors in the bone marrow and stimulates the production, maturation, and release of neutrophils into the bloodstream.

Chemotherapy can damage rapidly dividing cells, including those in the bone marrow, leading to reduced white blood cell counts. Pegasta helps the bone marrow recover more quickly by increasing neutrophil production, thereby reducing the risk of serious infections.

Its pegylated formulation allows it to remain active in the body for longer than filgrastim, making a single injection sufficient for many chemotherapy cycles.

---

How to Take Pegasta Injection 6 mg

General guidance includes:

• Use only as prescribed by your doctor.
• Administer as a subcutaneous injection.
• Usually given after chemotherapy according to your oncologist’s schedule.
• Do not self-inject unless you have received proper training.
• Do not change the prescribed schedule without consulting your doctor.
• If you miss a scheduled injection, contact your healthcare provider promptly for advice.
• Never use damaged or expired syringes.

---

Side Effects of Pegasta Injection 6 mg

Like all medicines, Pegasta Injection 6 mg may cause side effects, although not everyone experiences them.

Common Side Effects

• Bone pain
• Muscle pain
• Joint pain
• Headache
• Mild injection-site reactions
• Fatigue
• Nausea

Serious Side Effects

Seek immediate medical attention if you experience:

• Severe allergic reactions
• Difficulty breathing
• Chest pain
• Sudden swelling of the face or throat
• Persistent fever
• Severe abdominal pain (possible splenic complications)
• Symptoms of capillary leak syndrome (rapid swelling, dizziness, low blood pressure)
• Signs of acute respiratory distress

If side effects persist or become severe, contact your healthcare provider promptly.

---

Warnings and Precautions

Before using Pegasta Injection, inform your doctor if you:

• Are pregnant or planning pregnancy
• Are breastfeeding
• Have kidney or liver disease
• Have sickle cell disease
• Have a history of severe allergic reactions to pegfilgrastim or filgrastim
• Have previous spleen disorders
• Have lung disease or breathing problems

Pregnancy

Use only if the potential benefit outweighs possible risks, as determined by your physician.

Breastfeeding

Consult your healthcare provider before use.

Elderly Patients

Generally used with appropriate medical supervision.

Driving

Pegasta is not known to significantly impair driving ability, but avoid driving if you feel unwell after treatment.

Alcohol

No specific interaction is established, but discuss alcohol consumption with your healthcare provider during cancer treatment.

---

Drug Interactions

Pegasta may interact with certain medicines or treatments. Inform your doctor about all:

• Prescription medicines
• Over-the-counter medicines
• Herbal supplements
• Vitamins
• Recent or planned chemotherapy medicines

Your healthcare provider will determine the safest treatment schedule.

---

Storage Instructions

• Store refrigerated at 2°C to 8°C, unless otherwise directed by the manufacturer.
• Do not freeze. If accidentally frozen, consult a pharmacist or healthcare provider before use.
• Keep in the original carton to protect from light.
• Do not shake the syringe.
• Keep out of reach of children.
• Do not use after the expiry date.

---

Disclaimer

The information provided here is for educational purposes only and should not be considered medical advice. Pegasta Injection should only be used under the guidance of a qualified healthcare professional. Do not self-medicate or alter your prescribed treatment without consulting your doctor. Individual responses to treatment may vary.

---

Frequently Asked Questions (FAQs)

1. What is Pegasta Injection 6 mg used for?

Pegasta Injection is primarily used to reduce the risk of infection in patients receiving chemotherapy by increasing the production of neutrophils, a type of white blood cell that helps fight infections.

2. How does Pegasta work?

Pegasta contains Pegfilgrastim, which stimulates the bone marrow to produce more neutrophils, helping restore immune function after chemotherapy.

3. Is Pegasta a chemotherapy medicine?

No. Pegasta is not a chemotherapy drug. It is a supportive medicine used to help reduce chemotherapy-related complications caused by low white blood cell counts.

4. Can Pegasta be used long term?

It is typically used according to the chemotherapy cycle prescribed by your oncologist. Long-term use depends on individual treatment requirements.

5. What happens if I miss a dose?

Contact your doctor immediately. Do not administer an extra dose unless instructed by your healthcare provider.

6. Can I stop Pegasta on my own?

No. Always follow your oncologist’s recommendations. Stopping treatment without medical advice may increase the risk of infection.

7. Can Pegasta be taken with food?

Since Pegasta is administered by injection, food does not affect its action.

8. What are the most common side effects?

Bone pain, muscle pain, headache, fatigue, nausea, and mild injection-site reactions are among the most frequently reported side effects.

9. Who should avoid Pegasta Injection?

People with a known allergy to Pegfilgrastim, Filgrastim, or any ingredient in the formulation should avoid using this medicine unless specifically advised by a specialist.

10. How should Pegasta Injection be stored?

Store it in a refrigerator at 2°C–8°C, protect it from light, avoid freezing, and keep it in its original packaging until use